Eliyahu Sharon Kalif, EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 153,251 shares at $35.61 ($5.5M) on 2026-05-14, disclosed to the SEC on 2026-05-18.
Scheduled sale ($5.5M) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2025-06-16 | $1.9M | — | Filing → |
| TEVA | SELL | 2025-03-04 | $1.8M | — | Filing → |
| TEVA | SELL | 2024-03-07 | $1.0M | — | Filing → |